AI is Accelerating Drug Discovery: McKernan

SV Health Investors’ Ruth McKernan says wearables and health data are helping move medicine from the general to the personal. She says AI is already speeding up parts of drug discovery and improving patient selection for clinical trials. But McKernan says some parts of development cannot be rushed, and the UK still needs more funding to help life-sciences companies scale. She spoke to Tom Mackenzie on the latest episode of Bloomberg Tech: Europe. (Source: Bloomberg)

Read it at Bloomberg Markets ↗

← Front page